Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Journal of Biopharmaceutical Statistics|October 10, 2017
Statistical planning in confirmatory clinical trials with multiple treatment groups, multiple visits, and multiple endpointsHengrui Sun, Ellen Snyder, Gary G KochJournal of Biopharmaceutical Statistics|March 8, 2017
Statistical planning to address strongly correlated endpoints for inferential subgroups: An innovative approach for an illustrative clinical trial with complex multiplicity issuesHengrui Sun, Bruce Binkowitz, Gary G KochCirculation. Heart Failure|October 16, 2012
Evaluating treatment efficacy by multiple end points in phase II acute heart failure clinical trials: analyzing data using a global methodHengrui Sun, Beth A Davison, Gad Cotter, et al.Journal of Medicinal Chemistry|July 29, 2009
Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidineBenjamin L Barthel, Zhiyong Zhang, Daniel L Rudnicki, et al.Journal of Biopharmaceutical Statistics|July 9, 2008
Cumulative statistical power for hierarchical comparisons to evaluate two combination drug dosesTomoharu Matsukura, Gary G KochJournal of Biopharmaceutical Statistics|May 25, 2010
Multivariate Mann-Whitney estimators for the comparison of two treatments in a three-period crossover study with randomly missing dataAtsushi Kawaguchi, Gary G KochJournal of Biopharmaceutical Statistics|January 8, 2014
An overview of statistical planning to address subgroups in confirmatory clinical trialsGary G Koch, Todd A SchwartzJournal of Biopharmaceutical Statistics|February 11, 2005
Review and evaluation of methods for computing confidence intervals for the ratio of two proportions and considerations for non-inferiority clinical trialsRebekkah S Dann, Gary G KochJournal of Periodontology|March 15, 2018
Statistical Projection of Clinical Subsample Estimates to a Survey PopulationLisa M LaVange, Gary G KochJournal of Biopharmaceutical Statistics|February 27, 2013
Estimating covariate-adjusted log hazard ratios in randomized clinical trials using cox proportional hazards models and nonparametric randomization based analysis of covarianceBenjamin R Saville, Gary G KochPageof 14